A clinical risk model for assessing the survival of patients with stage IA–IIA non-small cell lung cancer after surgery

BACKGROUND: The survival of patients with stage IA–IIA non-small cell lung cancer (NSCLC) after surgery is heterogeneous. This study aimed to construct a prognostic risk model to predict the overall survival (OS) of these patients. METHODS: Data from patients (n=9,914) from the Surveillance Epidemio...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jia-Yi, Li, Zhi-Xin, Wu, Lei-Lei, Song, Si-Hui, Li, Chong-Wu, Lin, Wei-Kang, Xu, Shu-Quan, Li, Kun, Xie, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745515/
https://www.ncbi.nlm.nih.gov/pubmed/36524081
http://dx.doi.org/10.21037/jtd-22-890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745515/
https://www.ncbi.nlm.nih.gov/pubmed/36524081
http://dx.doi.org/10.21037/jtd-22-890

Ejemplares similares